Published in Neuropharmacology on April 24, 2017
Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 13.45
Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci (2006) 12.37
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96
Dopamine in motivational control: rewarding, aversive, and alerting. Neuron (2010) 6.26
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature (2001) 6.12
Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science (2004) 5.62
Endocannabinoid-mediated control of synaptic transmission. Physiol Rev (2009) 5.56
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci (1999) 4.65
Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron (2012) 4.59
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron (2001) 4.15
Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron (2001) 3.98
The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol (2006) 3.97
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science (1997) 3.77
Dopamine receptor signaling. J Recept Signal Transduct Res (2004) 3.47
Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron (2012) 3.33
The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron (2010) 3.28
Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron (2004) 3.16
Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron (2001) 2.94
Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature (2005) 2.84
Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat Neurosci (2008) 2.76
CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol (2010) 2.74
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci (2001) 2.69
Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci (2001) 2.48
Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci (2007) 2.32
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci U S A (1992) 2.23
Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron (2005) 2.23
Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron (2004) 2.20
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci (2004) 2.10
On the presence of 3-hydroxytyramine in brain. Science (1958) 2.03
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci (1996) 1.98
Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci (2007) 1.95
Structural basis of function in heterotrimeric G proteins. Q Rev Biophys (2006) 1.94
Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep (2012) 1.91
Endocannabinoid signaling and synaptic function. Neuron (2012) 1.90
Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice. Nat Neurosci (2011) 1.88
Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci (2009) 1.88
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci (2004) 1.85
Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron (2007) 1.81
Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron (2008) 1.81
Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci (2012) 1.78
Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol (1996) 1.75
Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci (2013) 1.73
Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol (2007) 1.69
Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology (2013) 1.67
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One (2007) 1.67
A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron (2013) 1.66
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol (2001) 1.63
Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci (2002) 1.61
Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci (2012) 1.60
Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol (2009) 1.56
Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci (2004) 1.52
Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem (1990) 1.51
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport (1997) 1.48
Two intracellular pathways mediate metabotropic glutamate receptor-induced Ca2+ mobilization in dopamine neurons. J Neurosci (2003) 1.44
Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology (2005) 1.42
Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc Natl Acad Sci U S A (2003) 1.41
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse (2000) 1.38
Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev (1966) 1.37
CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience (2005) 1.35
Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci U S A (2006) 1.35
The role of protein synthesis in striatal long-term depression. J Neurosci (2006) 1.34
Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum. PLoS One (2011) 1.30
Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav (2009) 1.29
Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci (2008) 1.29
A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J Neurophysiol (2010) 1.27
Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin. Proc Natl Acad Sci U S A (2008) 1.27
Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance. J Neurosci (2012) 1.25
Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci (2004) 1.25
The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat. Br J Pharmacol (1974) 1.24
A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons. Nat Commun (2014) 1.21
Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J Physiol (2004) 1.20
Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci (2007) 1.19
Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol (1992) 1.18
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology (2007) 1.15
Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J Neurosci (2004) 1.15
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron (2012) 1.13
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci U S A (2014) 1.13
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists. Trends Pharmacol Sci (2011) 1.13
Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterisation. J Neurochem (1990) 1.12
Endocannabinoid-mediated retrograde modulation of synaptic transmission. Curr Opin Neurobiol (2014) 1.11
The time course of dopamine transmission in the ventral tegmental area. J Neurosci (2009) 1.10
Cannabinoid receptors and reward in the rat: a conditioned place preference study. Psychopharmacology (Berl) (2000) 1.09
Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology (2007) 1.08
Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J Neurosci (2003) 1.08
Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience (2001) 1.07
Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J Neurosci (2003) 1.07
AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. EMBO J (2010) 1.05
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol Dis (2006) 1.04
Endocannabinoid signalling in reward and addiction. Nat Rev Neurosci (2015) 1.04
Role of the cyclic-AMP/PKA cascade and of P/Q-type Ca++ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens. Neuropharmacology (2007) 1.04
Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem (1991) 1.04
Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience (2003) 1.03
Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr Opin Neurobiol (2007) 1.02
Molecular characteristics of mammalian dopamine receptors. Pharmacol Toxicol (1997) 1.02
Release of newly synthesized dopamine from dopamine-containing terminals in the striatum of the rat. Proc Natl Acad Sci U S A (1969) 1.02
[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain. J Neurochem (1988) 1.01
AMPA receptor-dependent H2O2 generation in striatal medium spiny neurons but not dopamine axons: one source of a retrograde signal that can inhibit dopamine release. J Neurophysiol (2008) 0.99
Evidence for the preferential localization of glutamate receptor-1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum. Neuroscience (1998) 0.99
Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids. Eur J Neurosci (2016) 0.76
Endocannabinoid Regulation of Cocaine Reinforcement: an Upper or Downer? Neuropsychopharmacology (2016) 0.75
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens. Neuron (2017) 0.75